(Reuters) - TORONTO, July 16 - Shares of PreMD jumped more than 50 percent on Monday after the small Canadian biotechnology company signed a U.S. marketing deal with AstraZeneca Pharmaceuticals LP for its skin cholesterol test.
PreMD shares were up 60 Canadian cents, or 52.2 percent, at C$1.75 at midmorning on the Toronto Stock Exchange.
Read more at Reuters.com Hot Stocks News
PreMD shares were up 60 Canadian cents, or 52.2 percent, at C$1.75 at midmorning on the Toronto Stock Exchange.
Read more at Reuters.com Hot Stocks News
No comments:
Post a Comment